BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 10615243)

  • 21. Phage display selection of fully human antibody fragments to inhibit growth-promoting effects of glycine-extended gastrin 17 on human colorectal cancer cells.
    Khajeh S; Tohidkia MR; Aghanejad A; Mehdipour T; Fathi F; Omidi Y
    Artif Cells Nanomed Biotechnol; 2018; 46(sup2):1082-1090. PubMed ID: 29886758
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glycine-extended gastrin acts as an autocrine growth factor in a nontransformed colon cell line.
    Hollande F; Imdahl A; Mantamadiotis T; Ciccotosto GD; Shulkes A; Baldwin GS
    Gastroenterology; 1997 Nov; 113(5):1576-88. PubMed ID: 9352860
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glycine-extended gastrin exerts growth-promoting effects on human colon cancer cells.
    Stepan VM; Sawada M; Todisco A; Dickinson CJ
    Mol Med; 1999 Mar; 5(3):147-59. PubMed ID: 10404512
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-Gastrins Antiserum Combined with Lowered Dosage Cytotoxic Drugs to Inhibit the Growth of Human Gastric Cancer SGC7901 Cells in Nude Mice.
    He Q; Gao H; Gao M; Qi S; Zhang Y; Wang J
    J Cancer; 2015; 6(5):448-56. PubMed ID: 25874008
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gastrin sensitivity of primary human colorectal cancer: the effect of gastrin receptor antagonism.
    Watson SA; Clifford T; Sykes RE; Robinson E; Steele RJ
    Eur J Cancer; 1995 Nov; 31A(12):2086-92. PubMed ID: 8562170
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunogenicity and safety of a novel tetanus toxoid-conjugated anti-gastrin vaccine in BALB/c mice.
    He Q; Gao H; Gao M; Qi S; Yang K; Zhang Y; Wang J
    Vaccine; 2018 Feb; 36(6):847-852. PubMed ID: 29306507
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of CCKB/gastrin receptor isoforms in gastro-intestinal tumour cells.
    Watson SA; Clarke PA; Smith AM; Varro A; Michaeli D; Grimes S; Caplin M; Hardcastle JD
    Int J Cancer; 1998 Aug; 77(4):572-7. PubMed ID: 9679761
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intracellular gastrin in human gastrointestinal tumor cells.
    Watson SA; Durrant LG; Wencyk PM; Watson AL; Morris DL
    J Natl Cancer Inst; 1991 Jun; 83(12):866-71. PubMed ID: 2061947
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The C-terminal flanking peptide of progastrin induces gastric cell apoptosis and stimulates colonic cell division in vivo.
    Marshall KM; Patel O; Bramante G; Laval M; Yim M; Baldwin GS; Shulkes A
    Peptides; 2013 Aug; 46():83-93. PubMed ID: 23742999
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chimeric (mouse/human) anti-colon cancer antibody c30.6 inhibits the growth of human colorectal cancer xenografts in scid/scid mice.
    Mount PF; Sutton VR; Li W; Burgess J; McKEnzie IF; Pietersz GA; Trapani JA
    Cancer Res; 1994 Dec; 54(23):6160-6. PubMed ID: 7954462
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gastrin: growth enhancing effects on human gastric and colonic tumour cells.
    Watson S; Durrant L; Morris D
    Br J Cancer; 1989 Apr; 59(4):554-8. PubMed ID: 2713241
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression and processing of gastrin in pancreatic adenocarcinoma.
    Caplin M; Savage K; Khan K; Brett B; Rode J; Varro A; Dhillon A
    Br J Surg; 2000 Aug; 87(8):1035-40. PubMed ID: 10931047
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiserum raised against an epitope of the cholecystokinin B/gastrin receptor inhibits hepatic invasion of a human colon tumor.
    Watson SA; Clarke PA; Morris TM; Caplin ME
    Cancer Res; 2000 Oct; 60(20):5902-7. PubMed ID: 11059789
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression, processing, and secretion of gastrin in patients with colorectal carcinoma.
    Ciccotosto GD; McLeish A; Hardy KJ; Shulkes A
    Gastroenterology; 1995 Oct; 109(4):1142-53. PubMed ID: 7557079
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gastrins, cholecystokinins and gastrointestinal cancer.
    Aly A; Shulkes A; Baldwin GS
    Biochim Biophys Acta; 2004 Jul; 1704(1):1-10. PubMed ID: 15238241
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Construction and evaluation of anti-gastrin immunogen based on P64K protein.
    Xiong XH; Zhao HL; Xue C; Zhang W; Yang BF; Yao XQ; Liu ZM
    World J Gastroenterol; 2006 Apr; 12(13):2040-6. PubMed ID: 16610054
    [TBL] [Abstract][Full Text] [Related]  

  • 37. G17DT: an antigastrin immunogen for the treatment of gastrointestinal malignancy.
    Gilliam AD; Watson SA
    Expert Opin Biol Ther; 2007 Mar; 7(3):397-404. PubMed ID: 17309331
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gastrin mediates resistance to hypoxia-induced cell death in xenografts of the human colorectal cancer cell line LoVo.
    Westwood DA; Patel O; Baldwin GS
    Biochim Biophys Acta; 2014 Nov; 1843(11):2471-80. PubMed ID: 24998603
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glycine-extended gastrin promotes the growth of lung cancer.
    Koh TJ; Field JK; Varro A; Liloglou T; Fielding P; Cui G; Houghton J; Dockray GJ; Wang TC
    Cancer Res; 2004 Jan; 64(1):196-201. PubMed ID: 14729624
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Review article: gastrin and colorectal cancer.
    Smith AM; Watson SA
    Aliment Pharmacol Ther; 2000 Oct; 14(10):1231-47. PubMed ID: 11012467
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.